Shattuck Labs, Inc.

STTK

NASDAQ

Healthcare

Biotechnology

Austin, TX, US44 employeesshattucklabs.com

$6.43

+0.18(2.96%)

Mkt Cap $308M

$0.73

$6.43

52-Week Range

At A Glance

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States.

Revenue is primarily driven by Collaboration Revenue (92%) and License (8%).

Most recently: and Exhibit 99.1 incorporated herein shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Excha (2026-03-05).

$308M

Market Cap

$461.6K

Revenue

-$23M

Net Income

Employees44

Fundamentals

How The Business Makes Money

Revenue by Segment

Collaboration Revenue92%($11M)

License8%($1M)

Activity

What Changed Recently

Financial Results

Mar 4, 2026

and Exhibit 99.1 incorporated herein shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Excha

Material Agreement

Jan 21, 2026

Entry into a Material Definitive Agreement. On January 22, 2026, Shattuck Labs, Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with

Other Event

Feb 4, 2026

Other Events On February 5, 2026, the Board of Directors (the “Board”) of Shattuck Labs, Inc. (the “Company”) determined that the 2026 annual meeting of stockho

Peer Companies

Company	Price	Change	Market Cap	P/E
OVIDOvid Therapeutics Inc.	$2.19	+1.62%	$332M	-12.0
CNTXContext Therapeutics Inc.	$2.73	+3.02%	$251M	-10.9
STROSutro Biopharma, Inc.	$23.67	-4.83%	$201M	-0.8
ZNTLZentalis Pharmaceuticals,...	$2.63	+2.14%	$186M	-1.2
CNTBConnect Biopharma Holding...	$3.00	+10.48%	$168M	-4.5
ARTVArtiva Biotherapeutics, I...	$6.76	+0.15%	$167M	-1.6
KLRSKalaris Therapeutics Inc	$5.78	-2.61%	$108M	-3.4
IFRXInflaRx N.V.	$0.92	+1.72%	$66M	-1.3

Analyst View

Company Profile

CIK0001680367

ISINUS82024L1035

CUSIP82024L103

Phone512 900 4690

Address500 West 5th Street, Austin, TX, 78703, US

SEC EDGAR